Yoon Seok Yeol's generation

Announcement of non-face-to-face treatment in earnest

Focus on specifying the establishment of the Pharmaceutical Innovation Committee

Yoon Seok-yeol, the power of the people, was elected in the 20th presidential election, signaling significant changes in the health care and pharmaceutical bio industries as a whole.

 

Some keywords that are drawing attention right now are "promoting remote non-face-to-face treatment" and "the establishment of a pharmaceutical bio-control tower." Yoon Seok-yeol, elected candidate, previously announced the advancement of the industry by promising to start telemedicine in earnest and establish a pharmaceutical bio-innovation committee directly under the Prime Minister during the election process.

 

Yoon, who confirmed his election on the 10th, predicted health care and pharmaceutical bio policies to be implemented as president over the next five years.

 

Yoon has pledged several health care policies differentiated from the Moon Jae In government.

 

Yoon said he would improve and upgrade temporary telemedicine to the "realization of non-face-to-face treatment" stage through regulatory reform, and resolve the health insurance bomb problem through Moon Jae In Care reform.

 

The pharmaceutical bio industry also declared securing super-gap technology.

 

This is why attention is drawn to specific movements surrounding the pharmaceutical bio-innovation committee directly under the Prime Minister.

 

Pledges related to pharmacist and pharmacy management were relatively dim, but just before the presidential election, the Korean Pharmaceutical Association and the people's power subrogation signed a policy agreement to form a consensus on the long-cherished desire of pharmacist society.

 

◆ Telemedicine in earnest= Yoon plans to expand digital healthcare through service innovation and introduction and support of a private business revitalization system.

 

In particular, it announced the expansion of non-face-to-face treatment pilot projects for islands, mountainous areas, and the underprivileged.

 

Yoon narrowed down telemedicine to "a reality that we should accept." The vision is to implement policies that do not conflict interests between the medical community and non-face-to-face care providers seeking new innovations so that everyone can enjoy innovative systems and high-tech benefits in the field of non-face-to-face care.

 

Non-face-to-face treatment, which was temporarily allowed due to the prolonged COVID-19 Pandemic, had a significant impact on the pharmacy industry as well as front-line hospitals and clinics.

 

After non-face-to-face treatment, a platform dedicated to non-face-to-face preparation and drug delivery has been industrialized, and drug delivery applications have been activated.

 

If elected Yoon begins non-face-to-face treatment in the future, the drug delivery platform is also expected to continue to grow.

 

In the process, attention is expected to be paid to whether elected Yoon will be able to establish and promote a reasonable non-face-to-face treatment policy to minimize conflicts with the medical community and the pharmaceutical society.

 

◆The establishment of the Pharmaceutical Bio Innovation Committee Yoon also issued a blueprint to create new native blockbuster drugs and build a global vaccine hub by establishing a pharmaceutical bio-innovation committee directly under the Prime Minister.

 

It plans to significantly strengthen national R&D support so that it can protect the lives and health of the people by establishing sovereignty over pharmaceutical bio.

 

In addition, Yoon promised to create an ecosystem that can cultivate key talents in the pharmaceutical bio industry and create jobs to grow the national economy and realize a pharmaceutical bio powerhouse.

 

Accordingly, the pharmaceutical bio industry seems to expect a lot of administrative and financial support from elected Yoon.

 

The KPBMA has been urging the pharmaceutical industry to strongly support the pharmaceutical industry by establishing a direct presidential organization to establish sovereignty over vaccines and drugs since 2017.

 

Shortly after candidate Yoon was elected, the KPBMA demanded again to specify the establishment of an organization directly under the Prime Minister.

 

The association believes that the way to establish health security and find a way to create new national wealth is to foster the pharmaceutical bio industry.

 

Yoon also expressed sympathy for the pharmaceutical industry's opinion.

 

Depending on when and how the Pharmaceutical Bio Innovation Committee will start its activities, national policy directions such as pharmaceutical bio R&D, policy financing, tax support, regulatory reform, and manpower training are expected to materialize.